ABCL vs. MSTY
ABCL (AbCellera Biologics Inc.) is a stock, while MSTY (YieldMax™ MSTR Option Income Strategy ETF) is Derivative Income fund actively managed by YieldMax. Over the past year, ABCL returned 147.62% vs -61.25% for MSTY. At a 0.36 correlation, their price movements are largely independent.
Performance
ABCL vs. MSTY - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABCL achieves a 67.25% return, which is significantly higher than MSTY's -14.73% return.
ABCL
- 1D
- -6.69%
- 1M
- 24.62%
- YTD
- 67.25%
- 6M
- 63.90%
- 1Y
- 147.62%
- 3Y*
- -5.56%
- 5Y*
- -26.11%
- 10Y*
- —
MSTY
- 1D
- -6.76%
- 1M
- -28.46%
- YTD
- -14.73%
- 6M
- -26.86%
- 1Y
- -61.25%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
ABCL vs. MSTY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ABCL AbCellera Biologics Inc. | 67.25% | 16.72% | -39.59% |
MSTY YieldMax™ MSTR Option Income Strategy ETF | -14.73% | -42.71% | 200.20% |
Correlation
The correlation between ABCL and MSTY is 0.36, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.36 |
Correlation (All Time) Calculated using the full available price history since Feb 23, 2024 | 0.36 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABCL vs. MSTY — Risk / Return Rank
ABCL
MSTY
ABCL vs. MSTY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and YieldMax™ MSTR Option Income Strategy ETF (MSTY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABCL | MSTY | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.89 | ||
| Sortino ratioReturn per unit of downside risk | +4.34 | ||
| Omega ratioGain probability vs. loss probability | 1.30 | 0.81 | +0.49 |
| Calmar ratioReturn relative to maximum drawdown | 2.70 | -0.86 | +3.56 |
| Martin ratioReturn relative to average drawdown | 4.94 | -1.31 | +6.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ABCL | MSTY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.88 | -1.02 | +2.89 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.39 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.50 | 0.26 | -0.75 |
Drawdowns
ABCL vs. MSTY - Drawdown Comparison
The maximum ABCL drawdown since its inception was -96.72%, which is greater than MSTY's maximum drawdown of -71.79%. Use the drawdown chart below to compare losses from any high point for ABCL and MSTY.
Loading charts...
Drawdown Indicators
| ABCL | MSTY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.72% | -71.79% | -24.93% |
Max Drawdown (1Y)Largest decline over 1 year | -54.94% | -71.79% | +16.85% |
Max Drawdown (3Y)Largest decline over 3 years | -75.72% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -92.64% | — | — |
Current DrawdownCurrent decline from peak | -90.29% | -66.48% | -23.81% |
Average DrawdownAverage peak-to-trough decline | -83.59% | -26.09% | -57.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 30.01% | 46.87% | -16.86% |
Volatility
ABCL vs. MSTY - Volatility Comparison
AbCellera Biologics Inc. (ABCL) has a higher volatility of 28.65% compared to YieldMax™ MSTR Option Income Strategy ETF (MSTY) at 17.01%. This indicates that ABCL's price experiences larger fluctuations and is considered to be riskier than MSTY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABCL | MSTY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.65% | 17.01% | +11.64% |
Volatility (6M)Calculated over the trailing 6-month period | 52.34% | 48.79% | +3.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 79.56% | 60.44% | +19.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 66.48% | 71.92% | -5.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 70.07% | 71.92% | -1.85% |
Dividends
ABCL vs. MSTY - Dividend Comparison
ABCL has not paid dividends to shareholders, while MSTY's dividend yield for the trailing twelve months is around 269.45%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
ABCL AbCellera Biologics Inc. | 0.00% | 0.00% | 0.00% |
MSTY YieldMax™ MSTR Option Income Strategy ETF | 269.45% | 294.61% | 104.56% |
Frequently Asked Questions
ABCL and MSTY have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABCL has higher volatility (28.65%) compared to MSTY (17.01%). In terms of maximum drawdown, ABCL dropped -96.72% vs MSTY's -71.79%.
ABCL currently has the higher Sharpe Ratio (1.88 vs -1.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABCL and MSTY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer